TFAP2C upregulates the GPX4 gene in tumor cells and regulates some ferroptosis regulators, such as epidermal growth factor receptor (EGFR), CDKN1A, and YAP1, thereby negatively regulating ferroptosis (Dai et al., 2020). Here, CDKN1A is linked to neoplasm.